Literature DB >> 21480238

Tumor microenvironment and progression.

Harold F Dvorak1, Valerie M Weaver, Thea D Tlsty, Gabriele Bergers.   

Abstract

Tumor blood vessels are heterogeneous, of at least six distinct types, are induced primarily by vascular endothelial growth factor-A (VEGF-A), and provide a potentially useful therapeutic target. Breast cancer is characterized by changes in the microenvironment that result in altered tensional homeostasis. Also, breast cancers arise as the result of epigenetic as well as genetic changes. Tumor blood vessel pericytes result, in part, from bone marrow precursor cells, and VEGF is a negative regulator of glioblastoma tumor cell invasion.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480238      PMCID: PMC3277953          DOI: 10.1002/jso.21709

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  29 in total

Review 1.  Endothelial-pericyte interactions in angiogenesis.

Authors:  Holger Gerhardt; Christer Betsholtz
Journal:  Cell Tissue Res       Date:  2003-07-22       Impact factor: 5.249

2.  PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Authors:  Steven Song; Andrew J Ewald; William Stallcup; Zena Werb; Gabriele Bergers
Journal:  Nat Cell Biol       Date:  2005-08-21       Impact factor: 28.824

Review 3.  The role of pericytes in blood-vessel formation and maintenance.

Authors:  Gabriele Bergers; Steven Song
Journal:  Neuro Oncol       Date:  2005-10       Impact factor: 12.300

4.  First steps of tumor-related angiogenesis.

Authors:  S Paku; N Paweletz
Journal:  Lab Invest       Date:  1991-09       Impact factor: 5.662

5.  Distensibility of single capillaries and venules in the rat and frog mesentery.

Authors:  G T Swayne; L H Smaje; D H Bergel
Journal:  Int J Microcirc Clin Exp       Date:  1989-02

6.  Tensional homeostasis and the malignant phenotype.

Authors:  Matthew J Paszek; Nastaran Zahir; Kandice R Johnson; Johnathon N Lakins; Gabriela I Rozenberg; Amit Gefen; Cynthia A Reinhart-King; Susan S Margulies; Micah Dembo; David Boettiger; Daniel A Hammer; Valerie M Weaver
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

7.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population.

Authors:  Daniel J Brat; Amilcar A Castellano-Sanchez; Stephen B Hunter; Marcia Pecot; Cynthia Cohen; Elizabeth H Hammond; Sarojini N Devi; Balveen Kaur; Erwin G Van Meir
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.

Authors:  M Lombaerts; T van Wezel; K Philippo; J W F Dierssen; R M E Zimmerman; J Oosting; R van Eijk; P H Eilers; B van de Water; C J Cornelisse; A-M Cleton-Jansen
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  73 in total

1.  Biophysical control of invasive tumor cell behavior by extracellular matrix microarchitecture.

Authors:  Shawn P Carey; Casey M Kraning-Rush; Rebecca M Williams; Cynthia A Reinhart-King
Journal:  Biomaterials       Date:  2012-03-08       Impact factor: 12.479

2.  Characterization of the mechanical properties of cancer cells in 3D matrices in response to collagen concentration and cytoskeletal inhibitors.

Authors:  Jessica E Kim; Daniel S Reynolds; Muhammad H Zaman; Michael Mak
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

Review 3.  The emerging role of exosomes in survivin secretion.

Authors:  Salma Khan; Heather Ferguson Bennit; Nathan R Wall
Journal:  Histol Histopathol       Date:  2014-07-14       Impact factor: 2.303

4.  Three-dimensional cell culture model for measuring the effects of interstitial fluid flow on tumor cell invasion.

Authors:  Alimatou M Tchafa; Arpit D Shah; Shafei Wang; Melissa T Duong; Adrian C Shieh
Journal:  J Vis Exp       Date:  2012-07-25       Impact factor: 1.355

Review 5.  Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?

Authors:  Martha L Arango-Rodriguez; Fernando Ezquer; Marcelo Ezquer; Paulette Conget
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

6.  Sports and childhood brain tumors: Can I play?

Authors:  Sébastien Perreault; Robert M Lober; Carissa Davis; Christopher Stave; Sonia Partap; Paul G Fisher
Journal:  Neurooncol Pract       Date:  2014-09-01

7.  Leading malignant cells initiate collective epithelial cell invasion in a three-dimensional heterotypic tumor spheroid model.

Authors:  Shawn P Carey; Alina Starchenko; Alexandra L McGregor; Cynthia A Reinhart-King
Journal:  Clin Exp Metastasis       Date:  2013-01-18       Impact factor: 5.150

8.  The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer.

Authors:  Kim Tran; Renee Risingsong; Darlene B Royce; Charlotte R Williams; Michael B Sporn; Patricia A Pioli; Lalji K Gediya; Vincent C Njar; Karen T Liby
Journal:  Carcinogenesis       Date:  2012-10-06       Impact factor: 4.944

Review 9.  Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease.

Authors:  Karen T Liby; Michael B Sporn
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

10.  Detection of extracellular matrix modification in cancer models with inverse spectroscopic optical coherence tomography.

Authors:  Graham L C Spicer; Samira M Azarin; Ji Yi; Scott T Young; Ronald Ellis; Greta M Bauer; Lonnie D Shea; Vadim Backman
Journal:  Phys Med Biol       Date:  2016-09-12       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.